Associations - PGR positive

PGR positive PGR positive	Uterine Corpus Leiomyosarcoma Uterine Corpus Leiomyosarcoma	PGR positive PGR positive	Uterine Corpus Leiomyosarcoma Uterine Corpus Leiomyosarcoma	Aromatase inhibitor Sensitive: A2 - Guideline	Aromatase inhibitor Sensitive: A2 - Guideline
PGR positive PGR positive	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	PGR positive PGR positive	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	anastrozole Sensitive: A2 - Guideline	anastrozole Sensitive: A2 - Guideline
PGR positive PGR positive	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	PGR positive PGR positive	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	letrozole Sensitive: A2 - Guideline	letrozole Sensitive: A2 - Guideline
PGR positive PGR positive	Uterine Corpus Leiomyosarcoma Uterine Corpus Leiomyosarcoma	PGR positive PGR positive	Uterine Corpus Leiomyosarcoma Uterine Corpus Leiomyosarcoma	medroxyprogesterone Sensitive: A2 - Guideline	medroxyprogesterone Sensitive: A2 - Guideline
PGR positive PGR positive	Uterine Corpus Leiomyosarcoma Uterine Corpus Leiomyosarcoma	PGR positive PGR positive	Uterine Corpus Leiomyosarcoma Uterine Corpus Leiomyosarcoma	megestrol Sensitive: A2 - Guideline	megestrol Sensitive: A2 - Guideline
PGR positive PGR positive	HER2 Positive Breast Cancer HER2 Positive Breast Cancer	PGR positive PGR positive	HER2 Positive Breast Cancer HER2 Positive Breast Cancer	trastuzumab Sensitive: B - Late Trials	trastuzumab Sensitive: B - Late Trials
PGR positive PGR positive	Uterine Cancer Uterine Cancer	PGR positive PGR positive	Uterine Cancer Uterine Cancer	anastrozole Sensitive: C2 – Inclusion Criteria	anastrozole Sensitive: C2 – Inclusion Criteria
PGR positive PGR positive	HER2 Positive Breast Cancer HER2 Positive Breast Cancer	PGR positive PGR positive	HER2 Positive Breast Cancer HER2 Positive Breast Cancer	AC Sensitive: C3 – Early Trials	AC Sensitive: C3 – Early Trials
PGR positive PGR positive	Uterine Corpus Leiomyosarcoma Uterine Corpus Leiomyosarcoma	PGR positive PGR positive	Uterine Corpus Leiomyosarcoma Uterine Corpus Leiomyosarcoma	anastrozole Sensitive: C3 – Early Trials	anastrozole Sensitive: C3 – Early Trials
PGR positive PGR positive	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	PGR positive PGR positive	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	Aromatase inhibitor Sensitive: C3 – Early Trials	Aromatase inhibitor Sensitive: C3 – Early Trials